Circadian rhythm disruption affects cancer progression through interconnected biological and social pathways. The International Agency for Research on Cancer classified night-shift work that disrupts circadian rhythms as a probable carcinogen. Epidemiological analyses led by Eva S. Schernhammer at Harvard School of Public Health have reported associations between long-term night-shift work and higher risks for certain cancers, illustrating population-level links that motivate mechanistic research.
Mechanisms
At the cellular level, disruption alters clock genes such as CLOCK and PER, which coordinate the timing of cell division, DNA repair, and metabolic processes. Work by Satchin Panda at the Salk Institute for Biological Studies has clarified how misaligned feeding and light exposure change peripheral clocks in tissues, producing temporal desynchrony that can favor tumor cell proliferation. Suppression of nocturnal melatonin, emphasized in studies by Russell J. Reiter at UT Health San Antonio, removes an antioxidant and oncostatic signal; lower melatonin coincides with increased oxidative stress and altered estrogen signaling in hormone-sensitive tissues. Circadian misalignment also promotes chronic inflammation, immune dysfunction, and insulin resistance, all of which create a microenvironment conducive to tumor initiation and progression. These pathways operate together rather than singly, so timing disturbance can amplify multiple pro-tumor processes simultaneously.
Clinical and societal consequences
Circadian disruption can influence not only cancer risk but also tumor aggressiveness and treatment response. Research into chronotherapy by Francis Lévi at Gustave Roussy has shown that the timing of chemotherapy can change toxicity and efficacy, indicating that tumors and normal tissues have different temporal sensitivities. From a public-health perspective, the burden is uneven: night and rotating shift work are concentrated in healthcare, transportation, manufacturing, and service sectors, producing occupational and territorial disparities in exposure. Urban light pollution and extended service economies further normalize night activity in some cultures, increasing environmental drivers of disruption. Mitigation strategies span individualized measures such as controlled light exposure and meal timing to policy interventions like shift scheduling reforms and workplace screening programs. Integrating circadian biology into oncology—through timing therapies, minimizing unnecessary nocturnal light, and protecting worker schedules—offers a translational route to reduce the impact of rhythm disruption on cancer progression.